This issue of the CAPS Newsletter discusses the following topics: 

• X-DEA Prescription Requirements
• Prescriptions Written by a Nurse Practitioner (NP) or Physician Assistant (PA)
• Insulin Part B vs. Part D Billing
• NDC Number does NOT mean a Product is "FDA Approved"
• PBM Processing Exclusion for Non-FDA Approved Drugs
• “Use as Directed”, “As Directed”, “Per Sliding Scale” Directions
• Prescription Origin Codes
• DAW Codes (According to CMS.gov)
• OIG/SAM Monthly Exclusion Checks 
• CAPS Department Contact Information

• This issue of CAPS Newsletter discusses the following topics:

  
  

  • X-DEA Prescription Requirements
  • Prescriptions Written by a Nurse Practitioner (NP) or Physician Assistant (PA)
  • Insulin Part B vs. Part D Billing
  • Issuance of Multiple Schedule II Prescriptions
  • Biennial Controlled Substance Inventory Count
  • “Use as Directed”, “As Directed”, “Per Sliding Scale” Directions
  • Multiple Physicians Listed on a Prescription
  • Humana Audit $5 Penalty Fee
  • OIG/SAM Monthly Exclusion Checks 
  • Meet your CAPS Team

CAPS would like to take a moment and remind everyone about some of the yearly compliance requirements.  It is recommended that all pharmacies take a minute and double check that these documents are not expired or the required training has been completed.  Failure to perform the required training could be a breach of contract and lead to potential fines or termination from contracts.